Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Details for Australian Patent Application No. 2011227021 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Arekar, Sneha G.; Johnston, Steven C.; Krawiec, Mariusz; Medek, Ales; Mudunuri, Praveen; Sullivan, Mark Jeffrey

Agent Cullens

Pub. Number AU-A-2011227021

PCT Pub. Number WO2011/116397

Priority 61/315,885 19.03.10 US

Filing date 21 March 2011

Wipo publication date 22 September 2011

International Classifications

C07D 215/56 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 - Quinolines

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/116397 Priority application(s): WO2011/116397

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227022-Novel compounds and compositions for targeting cancer stem cells

2011227017-Drainage systems for excess body fluids